Chemiker Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 24-06-2024
- Paid Up Capital ₹ 1.25 Cr
as on 24-06-2024
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.50 Cr
as on 24-06-2024
- Revenue 2780.30%
(FY 2022)
- Profit -10618.43%
(FY 2022)
- Net Worth -24.39%
(FY 2022)
- Total Assets 77.68%
(FY 2022)
About Chemiker Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.25 Cr.
The company currently has active open charges totaling ₹4.50 Cr.
Shyam Titirmare, Ajay Aloni, and Smita Aloni serve as directors at the Company.
- CIN/LLPIN
U24299MH2018PTC304732
- Company No.
304732
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Chemiker Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shyam Titirmare  | Director | 31-Jan-2018 | Current |
| Ajay Aloni | Director | 31-Jan-2018 | Current |
| Smita Aloni | Director | 13-Aug-2021 | Current |
Financial Performance and Corporate Structure Insights of Chemiker Pharmaceuticals.
Chemiker Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 2780.3% increase. The company also saw a substantial fall in profitability, with a 10618.43% decrease in profit. The company's net worth observed a substantial decline by a decrease of 24.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Chemiker Pharmaceuticals?
Unlock access to Chemiker Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Toolika Commercials Private LimitedActive 3 years 11 months
Ajay Aloni and Smita Aloni are mutual person
- Asmivilla Hospitality Private LimitedActive 1 year 1 month
Ajay Aloni and Smita Aloni are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 27 Sep 2021 | ₹4.50 Cr | Open |
How Many Employees Work at Chemiker Pharmaceuticals?
Unlock and access historical data on people associated with Chemiker Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemiker Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemiker Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
